RVL Pharmaceuticals plc (NASDAQ:RVLP) Q1 2023 Earnings Call Transcript

RVL Pharmaceuticals plc (NASDAQ:RVLP) Q1 2023 Earnings Call Transcript May 11, 2023

RVL Pharmaceuticals plc reports earnings inline with expectations. Reported EPS is $-0.12 EPS, expectations were $-0.12.

Operator: Good morning, everyone. My name is Todd, and I will be your conference operator. At this time, I’d like to welcome everyone to the RVL Pharmaceuticals First Quarter 2023 Financial Results Call. All lines have been placed on mute to prevent any background noise. After the...